Heparin Sodium Injection, Solution
NDC Package 63323-540-36

11-digit billing NDC: 63323054036 · Billing unit: ML · 750 ML per package
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Heparin Sodium injection is indicated for: •Prophylaxis and treatment of venous thrombosis and pulmonary embolism; •Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; •Atrial fibrillation with embolization; •Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); •Prevention of clotting in arterial and cardiac surgery; •Prophylaxis and treatment of peripheral arterial embolism. This formulation utilizes a injection, solution delivery system. Marketed by Fresenius Kabi Usa, Llc, this product is identified by NDC 63323-540 and is authorized under FDA application NDA017029.

Identification & Billing

NDC Package Code
63323-540-36
Package Description
25 VIAL in 1 TRAY / 30 mL in 1 VIAL (63323-540-33)
Product Code
63323-540
11-Digit Billing Format
63323054036
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
750 ML
RxNorm Crosswalk
  • RxCUI: 1361226 - heparin sodium, porcine 1000 UNT/ML Injectable Solution
  • RxCUI: 1361574 - heparin sodium, porcine 20,000 UNT/ML Injectable Solution
  • RxCUI: 1361574 - heparin sodium, porcine 20000 UNT/ML Injectable Solution
  • RxCUI: 1361615 - heparin sodium, porcine 5000 UNT/ML Injectable Solution
  • RxCUI: 1362831 - heparin sodium, porcine 10,000 UNT/ML Injectable Solution

Clinical Specifications

Proprietary Name
Heparin Sodium
Non-Proprietary Name
Heparin Sodium
Substance Name
Heparin Sodium
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Heparin Sodium Injection is indicated for: •Prophylaxis and treatment of venous thrombosis and pulmonary embolism; •Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; •Atrial fibrillation with embolization; •Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); •Prevention of clotting in arterial and cardiac surgery; •Prophylaxis and treatment of peripheral arterial embolism. •Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures.

Regulatory & Marketing

Labeler Name
Fresenius Kabi Usa, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA017029
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-22-1972
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J1644
Source: ASP
Inj heparin sodium per 1000u
HCPCS Dosage 1000 UNITS
Units / Pkg 750

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (63323-540). Click a package code to view its specific billing and regulatory data.

63323-540-01
25 VIAL in 1 TRAY / 1 mL in 1 VIAL
63323-540-11
25 VIAL in 1 TRAY / 10 mL in 1 VIAL
63323-540-13
25 VIAL in 1 TRAY / 1 mL in 1 VIAL (63323-540-03)
63323-540-15
25 VIAL in 1 TRAY / 10 mL in 1 VIAL (63323-540-05)
63323-540-31
25 VIAL in 1 TRAY / 30 mL in 1 VIAL
63323-540-57
25 VIAL, MULTI-DOSE in 1 TRAY / 10 mL in 1 VIAL, MULTI-DOSE
63323-540-67
25 VIAL, MULTI-DOSE in 1 TRAY / 10 mL in 1 VIAL, MULTI-DOSE (63323-540-07)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63323-540-36 identifies a specific commercial package of 25 vial in 1 tray / 30 ml in 1 vial (63323-540-33) of Heparin Sodium, a human prescription drug labeled by Fresenius Kabi Usa, Llc. This product is billed per "ML" milliliter and contains an estimated amount of 750 billable units per package. This injection, solution is formulated for intravenous; subcutaneous use and contains heparin sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fresenius Kabi Usa, Llc on February 22, 1972. The current certification is valid through December 31, 2027.

How is this Fresenius Kabi Usa, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63323054036. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 750 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63323-540-36
11-Digit CMS (5-4-2)
63323-0540-36

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.